Last reviewed · How we verify
NCT05191745
Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
Phase 3 trial testing Parasternal blocks in Coronary Artery Bypass Graft Surgery in 60 participants. Completed in 1 June 2024.
28 April 2023
Quick facts
| Lead sponsor | Jewish General Hospital |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 26 January 2022 |
| Primary completion | 28 April 2023 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Parasternal blocks — full drug profile →
- Standard of care
Conditions studied
- Coronary Artery Bypass Graft Surgery — all drugs for Coronary Artery Bypass Graft Surgery →
Sponsor
Jewish General Hospital
Who can join
18 and older, any sex, with Coronary Artery Bypass Graft Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary artery bypass grafting surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05191745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Parasternal blocks
Trials testing the same drug.
- NCT07232979 — M-TAPA Block for Analgesia After Open-Heart Surgery · NA · not yet recruiting
- NCT07232992 — Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Open-Heart Surgery · NA · not yet recruiting
Other recruiting trials for Coronary Artery Bypass Graft Surgery
Currently open trials in the same condition.
- NCT07035756 — Development of an Arterial Pressure Monitoring Set Fixation Apparatus · NA · recruiting
Other Jewish General Hospital trials
Trials by the same sponsor.
- NCT05188222 — Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery · Phase 4 · not yet recruiting
- NCT06701929 — The Impact of Fasting Duration on Quality of Recovery After Cesarean Section · recruiting
- NCT05719415 — Functional Pulmonary Capillary Surface Area in BPA for CTEPH · NA · recruiting
- NCT04678986 — ER2 and Deep Learning for Prediction of Adverse Health Outcomes · withdrawn
- NCT04893876 — The OPERa Study: Evaluating QoL After Rectal Cancer Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05191745 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jewish General Hospital
- Last refreshed: 10 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05191745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing